Xiaobo Wang, Mark R. Sommerfeld, Kerstin Jahn‐Hofmann, Bishuang Cai, Aveline Filliol, Helen E. Remotti, Robert F. Schwabe, Aimo Kannt, Ira Tabas – 23 July 2019 – Nonalcoholic steatohepatitis (NASH) is emerging as a major public health issue and is associated with significant liver‐related morbidity and mortality. At present, there are no approved drug therapies for NASH.
Guido Carpino, Lorenzo Nevi, Diletta Overi, Vincenzo Cardinale, Wei‐Yu Lu, Sabina Di Matteo, Samira Safarikia, Pasquale Bartolomeo Berloco, Rosanna Venere, Paolo Onori, Antonio Franchitto, Stuart J. Forbes, Domenico Alvaro, Eugenio Gaudio – 22 July 2019
Jose Castellote, José Maria Mora Luján, Antoni Riera‐Mestre – 22 July 2019
Narendra S. Choudhary, Sanjiv Saigal, Arvinder S. Soin – 22 July 2019
Zhao‐Ning Lu, Qing Luo, Li‐Nan Zhao, Yi Shi, Na Wang, Lan Wang, Ze‐Guang Han – 20 July 2019
Yoosoo Chang, Seungho Ryu, Yejin Kim, Yong Kyun Cho, Eunju Sung, Han‐Na Kim, Jiin Ahn, Hyun‐Suk Jung, Kyung Eun Yun, Seolhye Kim, Ki‐Chul Sung, Chong Il Sohn, Hocheol Shin, Sarah H. Wild, Christopher D. Byrne – 19 July 2019
Mussarat N. Rahim, Michael A. Heneghan – 19 July 2019
Nassim Dali‐Youcef, Michel Vix, Federico Costantino, Houssein El‐Saghire, Benoit Lhermitte, Cosimo Callari, Jacopo D’Agostino, Silvana Perretta, Stefan Paveliu, Monica Gualtierotti, Edith Dumeny, Marine A. Oudot, Amélie Jaulin, Doulaye Dembélé, Mirjam B. Zeisel, Catherine Tomasetto, Thomas F. Baumert, Michel Doffoël – 19 July 2019 – Nonalcoholic fatty liver disease (NAFLD) is a metabolic disorder due to increased accumulation of fat in the liver and in many cases to enhanced inflammation.